Preferential nuclear localization of the human papillomavirus type 16 E6 oncoprotein in cervical carcinoma cells

References

1. Bernhard W. 1969; A new staining procedure for electron microscopical cytology. J Ultrastruct Res 27:250–265
   [Google Scholar]
2. Choulier L., Orfanoudakis G., Robinson P., Laune D., Ben Khalifa M., Granier C., Weiss E., Altschuh D. 2002; Comparative properties of two peptide–antibody interactions as deduced from epitope delineation. J Immunol Methods 259:77–86
   [Google Scholar]
3. Cmarko D., Verschure P. J., Martin T. E., Dahmus M. E., Krause S., Fu X. D., van Driel R., Fakan S. 1999; Ultrastructural analysis of transcription and splicing in the cell nucleus after bromo-UTP microinjection. Mol Biol Cell 10:211–223
   [Google Scholar]
4. Daniels P. R., Sanders C. M., Maitland N. J. 1998; Characterization of the interactions of human papillomavirus type 16 E6 with p53 and E6-associated protein in insect and human cells. J Gen Virol 79:489–499
   [Google Scholar]
5. Giovane C., Travé G., Briones A., Lutz Y., Wasylyk B., Weiss E. 1999; Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53. J Mol Recognit 12:141–152
   [Google Scholar]
6. Gross-Mesilaty S., Reinstein E., Bercovich B., Tobias K. E., Schwartz A. L., Kahana C., Ciechanover A. 1998; Basal and human papillomavirus E6 oncoprotein-induced degradation of Myc proteins by the ubiquitin pathway. Proc Natl Acad Sci U S A 95:8058–8063
   [Google Scholar]
7. Guccione E., Massimi P., Bernat A., Banks L. 2002; Comparative analysis of the intracellular location of the high- and low-risk human papillomavirus oncoproteins. Virology 293:20–25
   [Google Scholar]
8. Hendzel M. J., Kruhlak M. J., Bazett-Jones D. P. 1998; Organization of highly acetylated chromatin around sites of heterogeneous nuclear RNA accumulation. Mol Biol Cell 9:2491–2507
   [Google Scholar]
9. Kanda T., Watanabe S., Zanma S., Sato H., Furuno A., Yoshiike K. 1991; Human papillomavirus type 16 E6 proteins with glycine substitution for cysteine in the metal-binding motif. Virology 185:536–543
   [Google Scholar]
10. Klingelhutz A. J., Foster S. A., McDougall J. K. 1996; Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 380:79–82
    [Google Scholar]
11. Kumar A., Zhao Y., Meng G. 9 other authors 2002; Human papillomavirus oncoprotein E6 inactivates the transcriptional coactivator human ADA3. Mol Cell Biol 22:5801–5812
    [Google Scholar]
12. Lechner M. S., Mack D. H., Finicle A. B., Crook T., Vousden K. H., Laimins L. A. 1992; Human papillomavirus E6 proteins bind p53 in vivo and abrogate p53-mediated repression of transcription. EMBO J 11:3045–3052
    [Google Scholar]
13. Le Roux L. G., Moroianu J. 2003; Nuclear entry of high-risk human papillomavirus type 16 E6 oncoprotein occurs via several pathways. J Virol 77:2330–2337
    [Google Scholar]
14. Liang X. H., Volkmann M., Klein R., Herman B., Lockett S. J. 1993; Co-localization of the tumor-suppressor protein p53 and human papillomavirus E6 protein in human cervical carcinoma cell lines. Oncogene 8:2645–2652
    [Google Scholar]
15. Mantovani F., Banks L. 2001; The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874–7887
    [Google Scholar]
16. Patel D., Huang S. M., Baglia L. A., McCance D. J. 1999; The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300. EMBO J 18:5061–5072
    [Google Scholar]
17. Pim D., Thomas M., Javier R., Gardiol D., Banks L. 2000; HPV E6 targeted degradation of the discs large protein: evidence for the involvement of a novel ubiquitin ligase. Oncogene 19:719–725
    [Google Scholar]
18. Ristriani T., Masson M., Nominé Y., Laurent C., Lefèvre J. F., Weiss E., Travé G. 2000; HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions. J Mol Biol 296:1189–1203
    [Google Scholar]
19. Ristriani T., Nominé Y., Masson M., Weiss E., Travé G. 2001; Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6. J Mol Biol 305:729–739
    [Google Scholar]
20. Ronco L. V., Karpova A. Y., Vidal M., Howley P. M. 1998; Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity. Genes Dev 12:2061–2072
    [Google Scholar]
21. Scheffner M., Takahashi T., Huibregtse J. M., Minna J. D., Howley P. M. 1992; Interaction of the human papillomavirus type 16 E6 oncoprotein with wild-type and mutant human p53 proteins. J Virol 66:5100–5105
    [Google Scholar]
22. Schwalbach G., Sibler A. P., Choulier L., Deryckere F., Weiss E. 2000; Production of fluorescent single-chain antibody fragments in Escherichia coli . Protein Expr Purif 18:121–132
    [Google Scholar]
23. Sherman L., Schlegel R. 1996; Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J Virol 70:3269–3279
    [Google Scholar]
24. Sorg G., Stamminger T. 1999; Mapping of nuclear localization signals by simultaneous fusion to green fluorescent protein and to β -galactosidase. Biotechniques 26:858–862
    [Google Scholar]
25. Spector D. L., Fu X. D., Maniatis T. 1991; Associations between distinct pre-mRNA splicing components and the cell nucleus. EMBO J 10:3467–3481
    [Google Scholar]
26. Stoeckel M. E., Schimchowitsch S., Garaud J. C., Schmitt G., Vaudry H., Klein M. J., Porte A. 1985; Immunocytochemical evidence for intragranular processing of pro-opiomelanocortin in the melanotropic cells of the rabbit. Cell Tissue Res 242:365–370
    [Google Scholar]
27. Weiss D. J., Ligitt D., Clark J. G. 1997; In situ histochemical detection of β -galactosidase activity in lung: assessment of X-Gal reagent in distinguishing lacZ gene expression and endogeous β -galactosidase activity. Hum Gene Ther 8:1545–1554
    [Google Scholar]
28. Yoneda Y. 2000; Nucleocytoplasmic protein traffic and its significance to cell function. Genes Cells 5:777–787
    [Google Scholar]
29. zur Hausen H. 1999; Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Semin Cancer Biol 9:405–411
    [Google Scholar]